TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.
TenSixty BioSciences's investors include General Catalyst, Wing Venture Capital, Intel Ignite.
TenSixty BioSciences is headquartered in Cambridge, United States.
TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.
TenSixty BioSciences is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TenSixty BioSciences — Funding & Investors." VCBacked, May 9, 2023, https://www.vcbacked.co/company/tensixty-biosciences. Accessed September 30, 2026.
VCBacked. (2023). TenSixty BioSciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/tensixty-biosciences
{{cite web |title=TenSixty BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/tensixty-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated